Related Experiment Video
Updated: May 7, 2026
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Home parenteral nutrition in children with Crohn's disease: an effective management alternative
Insights
Home parenteral nutrition (HPN) effectively induced remission and improved growth in pediatric Crohn's disease patients unresponsive to conventional therapies. HPN offers a safe and effective treatment option for severe cases.
Area of Science:
- Pediatric Gastroenterology
- Clinical Nutrition
- Inflammatory Bowel Disease
Background:
- Severe Crohn's disease in pediatric patients often presents with significant symptoms and poor response to standard treatments.
- Previous therapies including sulfasalazine, corticosteroids, inpatient total parenteral nutrition, and surgery failed to control disease activity in the studied cohort.
- Optimal nutritional support and disease remission are critical for growth and development in pediatric patients with Crohn's disease.
Purpose of the Study:
- To evaluate the efficacy and safety of home parenteral nutrition (HPN) in inducing remission and supporting nutritional status in pediatric patients with severe Crohn's disease.
- To assess the long-term maintenance of remission after HPN discontinuation.
- To identify potential predictors of relapse following HPN treatment.
Main Methods:
- Seventeen pediatric patients with severe, symptomatic Crohn's disease were enrolled in a home parenteral nutrition (HPN) program.
- Patients received HPN due to failure of prior medical and/or surgical interventions.
- Disease activity, nutritional status, growth parameters, and complications were monitored during and after HPN therapy.
Main Results:
- Remission was achieved in 12 out of 17 patients with HPN alone; 4 required additional interventions (surgery or steroids).
- All patients experienced marked symptom improvement and weight gain, with 10 showing "catch-up" growth.
- Complications were minimal, with a low rate of sepsis (1 episode per 5.8 catheter years).
- Elevated chromium 51-labeled albumin levels (>1%) predicted relapse within 4 months in 5 of 7 patients.
Conclusions:
- Home parenteral nutrition (HPN) is a safe and effective therapeutic modality for inducing remission and providing nutritional support in pediatric patients with severe Crohn's disease.
- HPN should be considered for pediatric Crohn's disease patients who do not respond adequately to standard medical management.
- Monitoring nutritional markers like albumin may help predict relapse after HPN treatment.
Abstract:
Seventeen pediatric patients, ages 9.25--20.5 yr, were placed on a program of home parenteral nutrition (HPN) for severe, symptomatic Crohn's disease. Prior therapy with sulfasalazine in 14, adrenocorticosteroids in 12, inpatient total parenteral nutrition in 7, and/or surgical resections in 6 failed to suppress disease activity. Remission was attained in 12 of the 17 after one course of HPN alone. Four patients had surgical procedures and 1 required steroids in addition to HPN. Remissions have been maintained in 4 of those 12 for a mean duration of 315 days after discontinuation of HPN. Of the 8 who relapsed after a mean duration of 68 days, second courses of HPN were undertaken in 7 and third courses in 2. All 17 had a marked improvement in disease symptoms while receiving HPN in addition to gaining weight sufficient to place them at a higher percentile on standard growth charts. Ten patients demonstrated "catch-up" growth and 4 others increased their height appropriately. A chromium 51-labeled albumin stool collection of greater than 1% in 5 of 7 patients at the completion of a HPN course correlated with relapse within 4 mo. Serial radiographic contrast studies and erythrocyte sedimentation rates were not predictive of prolonged remissions. Home parenteral nutrition complications were minimal, with only one episode of sepsis per 5.8 catheter experience years. It is concluded that HPN is a safe and effective means of inducing remissions and providing optimal nutritional support in pediatric patients with severe Crohn's disease. Patients with less than adequate response to standard medical management should be considered candidates for this therapeutic modality.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:25Inflammatory Bowel Disease III: Crohn's Disease